| NVO |
Novo Nordisk A/S |
$39.05 |
$172.63B |
9.65 |
59.09% |
2.99% |
| VRTX |
Vertex Pharmaceuticals Incorporated |
$523.93 |
$132.80B |
30.38 |
23.31% |
— |
| REGN |
Regeneron Pharmaceuticals, Inc. |
$805.02 |
$82.88B |
18.82 |
13.81% |
0.48% |
| MRNA |
Moderna, Inc. |
$200.10 |
$79.89B |
— |
-39.20% |
— |
| RVMD |
Revolution Medicines, Inc. |
$186.99 |
$40.08B |
— |
-96.44% |
— |
| ALNY |
Alnylam Pharmaceuticals, Inc. |
$224.03 |
$29.98B |
36.02 |
93.61% |
— |
| RPRX |
Royalty Pharma plc |
$63.86 |
$28.44B |
24.15 |
12.25% |
1.61% |
| ROIV |
Roivant Sciences Ltd. |
$36.49 |
$26.36B |
— |
-6.12% |
— |
| UTHR |
United Therapeutics Corporation |
$587.50 |
$25.20B |
17.74 |
20.18% |
— |
| INCY |
Incyte Corporation |
$115.71 |
$23.45B |
15.15 |
29.70% |
— |
| INSM |
Insmed Incorporated |
$93.39 |
$20.39B |
— |
-111.26% |
— |
| EXEL |
Exelixis, Inc. |
$64.53 |
$16.22B |
17.78 |
42.49% |
— |
| ASND |
Ascendis Pharma A/S - Ordinary Share |
$243.37 |
$15.18B |
16.85 |
— |
— |
| NBIX |
Neurocrine Biosciences, Inc. |
$142.70 |
$14.51B |
20.05 |
21.13% |
— |
| HALO |
Halozyme Therapeutics, Inc. |
$125.63 |
$14.26B |
30.77 |
180.63% |
— |
| JAZZ |
Jazz Pharmaceuticals plc |
$214.00 |
$13.89B |
15.33 |
— |
— |
| BBIO |
BridgeBio Pharma, Inc. |
$68.56 |
$13.40B |
— |
— |
— |
| SMMT |
Summit Therapeutics Inc. |
$15.47 |
$12.34B |
— |
-204.33% |
— |
| TECH |
Bio-Techne Corp |
$72.55 |
$11.38B |
61.86 |
8.90% |
0.44% |
| BMRN |
BioMarin Pharmaceutical Inc. |
$55.95 |
$10.83B |
151.42 |
1.18% |
— |
| MDGL |
Madrigal Pharmaceuticals, Inc. |
$434.24 |
$10.03B |
— |
-56.65% |
— |
| PCVX |
Vaxcyte, Inc. |
$60.43 |
$9.51B |
— |
-37.57% |
— |
| CORT |
Corcept Therapeutics Incorporated |
$85.86 |
$9.28B |
221.60 |
8.37% |
— |
| KRYS |
Krystal Biotech, Inc. |
$311.50 |
$9.22B |
38.97 |
19.34% |
— |
| KYMR |
Kymera Therapeutics, Inc. |
$110.76 |
$9.11B |
— |
-21.50% |
— |
| CAI |
Caris Life Sciences, Inc. |
$32.00 |
$9.05B |
81.72 |
— |
— |
| PTGX |
Protagonist Therapeutics, Inc. |
$138.43 |
$8.96B |
115.66 |
— |
— |
| IBRX |
ImmunityBio, Inc. |
$8.22 |
$8.71B |
— |
— |
— |
| CYTK |
Cytokinetics, Incorporated |
$61.23 |
$8.51B |
— |
— |
— |
| SYRE |
Spyre Therapeutics, Inc. |
$90.33 |
$8.34B |
— |
-24.32% |
— |
| TGTX |
TG Therapeutics, Inc. |
$54.17 |
$8.29B |
17.83 |
72.30% |
— |
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
$58.02 |
$8.20B |
— |
-60.54% |
— |
| AXSM |
Axsome Therapeutics, Inc. |
$145.04 |
$7.60B |
— |
-255.60% |
— |
| ALKS |
Alkermes plc |
$43.63 |
$7.32B |
103.60 |
3.72% |
— |
| IONS |
Ionis Pharmaceuticals, Inc. |
$42.93 |
$7.13B |
— |
-110.84% |
— |
| PRAX |
Praxis Precision Medicines, Inc. |
$252.96 |
$7.06B |
— |
-34.15% |
— |
| IOVA |
Iovance Biotherapeutics, Inc. |
$14.09 |
$6.38B |
— |
-40.51% |
— |
| RYTM |
Rhythm Pharmaceuticals, Inc. |
$89.27 |
$6.15B |
— |
-80.48% |
— |
| LGND |
Ligand Pharmaceuticals Incorporated |
$303.53 |
$6.05B |
31.21 |
20.06% |
— |
| KNSA |
Kiniksa Pharmaceuticals International, plc |
$76.73 |
$5.99B |
70.83 |
13.65% |
— |
| IMVT |
Immunovant, Inc. |
$28.41 |
$5.87B |
— |
-69.59% |
— |
| MANE |
Veradermics, Incorporated |
$138.78 |
$5.80B |
— |
-37.51% |
— |
| KOD |
Kodiak Sciences Inc |
$87.63 |
$5.51B |
— |
-273.23% |
— |
| CGON |
CG Oncology, Inc. |
$61.71 |
$5.47B |
— |
-25.20% |
— |
| COGT |
Cogent Biosciences, Inc. |
$31.21 |
$5.42B |
— |
-72.57% |
— |
| ORKA |
Oruka Therapeutics, Inc. |
$80.15 |
$5.31B |
— |
-20.76% |
— |
| MIRM |
Mirum Pharmaceuticals, Inc. |
$80.39 |
$5.22B |
— |
— |
— |
| PTCT |
PTC Therapeutics, Inc. |
$60.59 |
$5.06B |
— |
— |
— |
| SRRK |
Scholar Rock Holding Corporation |
$41.49 |
$5.05B |
— |
-160.19% |
— |
| ERAS |
Erasca, Inc. |
$14.39 |
$5.03B |
— |
-80.43% |
— |
| DFTX |
Definium Therapeutics, Inc. |
$35.67 |
$4.79B |
— |
-85.23% |
— |
| CRSP |
CRISPR Therapeutics AG |
$49.39 |
$4.78B |
— |
-24.39% |
— |
| TVTX |
Travere Therapeutics, Inc. |
$50.08 |
$4.72B |
— |
-55.79% |
— |
| DNTH |
Dianthus Therapeutics, Inc. |
$76.78 |
$4.29B |
— |
-3.51% |
— |
| EWTX |
Edgewise Therapeutics, Inc. |
$39.31 |
$4.23B |
— |
-39.01% |
— |
| ADPT |
Adaptive Biotechnologies Corporation |
$25.51 |
$4.07B |
— |
-32.64% |
— |
| RLAY |
Relay Therapeutics, Inc. |
$18.18 |
$3.98B |
— |
-42.27% |
— |
| TNGX |
Tango Therapeutics, Inc. |
$23.34 |
$3.94B |
— |
-25.74% |
— |
| ARQT |
Arcutis Biotherapeutics, Inc. |
$31.20 |
$3.92B |
113.95 |
— |
— |
| VCYT |
Veracyte, Inc. |
$47.93 |
$3.85B |
31.81 |
8.64% |
— |
| ABCL |
AbCellera Biologics Inc. |
$11.82 |
$3.83B |
— |
-17.49% |
— |
| LQDA |
Liquidia Corporation |
$42.65 |
$3.82B |
19.28 |
— |
— |
| XENE |
Xenon Pharmaceuticals Inc. |
$35.34 |
$3.42B |
— |
-43.98% |
— |
| AMLX |
Amylyx Pharmaceuticals, Inc. |
$27.20 |
$3.41B |
— |
-52.92% |
— |
| ACAD |
ACADIA Pharmaceuticals Inc. |
$19.73 |
$3.40B |
8.87 |
32.39% |
— |
| IDYA |
IDEAYA Biosciences, Inc. |
$34.71 |
$3.35B |
— |
-16.47% |
— |
| CELC |
Celcuity Inc. |
$65.25 |
$3.19B |
— |
— |
— |
| TARS |
Tarsus Pharmaceuticals, Inc. |
$68.20 |
$3.19B |
— |
-13.53% |
— |
| VKTX |
Viking Therapeutics, Inc. |
$24.40 |
$3.10B |
— |
-94.56% |
— |
| ELVN |
Enliven Therapeutics, Inc. |
$41.52 |
$3.04B |
— |
-18.55% |
— |
| PBLS |
Parabilis Medicines, Inc. |
$24.44 |
$2.98B |
— |
-15.14% |
— |
| DNLI |
Denali Therapeutics Inc. |
$18.41 |
$2.94B |
— |
-55.27% |
— |
| DYN |
Dyne Therapeutics, Inc. |
$15.62 |
$2.92B |
— |
-64.30% |
— |
| IRON |
Disc Medicine, Inc. |
$74.51 |
$2.86B |
— |
-37.17% |
— |
| NRIX |
Nurix Therapeutics, Inc. |
$25.34 |
$2.77B |
— |
-76.09% |
— |
| VRDN |
Viridian Therapeutics, Inc. |
$22.37 |
$2.53B |
— |
-61.35% |
— |
| BEAM |
Beam Therapeutics Inc. |
$24.05 |
$2.48B |
— |
-7.70% |
— |
| ADMA |
ADMA Biologics Inc |
$10.68 |
$2.39B |
14.08 |
39.59% |
— |
| MBX |
MBX Biosciences, Inc. |
$48.50 |
$2.34B |
— |
-26.01% |
— |
| RCUS |
Arcus Biosciences, Inc. |
$18.54 |
$2.33B |
— |
-87.98% |
— |
| SLS |
SELLAS Life Sciences Group, Inc. |
$11.54 |
$2.33B |
— |
-35.91% |
— |
| NAMS |
NewAmsterdam Pharma Company N.V. |
$19.71 |
$2.30B |
— |
-38.33% |
— |
| CLDX |
Celldex Therapeutics, Inc. |
$29.25 |
$2.30B |
— |
-52.36% |
— |
| FTRE |
Fortrea Holdings Inc. |
$23.63 |
$2.25B |
— |
-15.53% |
— |
| AUPH |
Aurinia Pharmaceuticals Inc |
$16.86 |
$2.24B |
6.71 |
59.00% |
— |
| PGEN |
Precigen, Inc. |
$6.19 |
$2.22B |
— |
— |
— |
| AGIO |
Agios Pharmaceuticals, Inc. |
$37.00 |
$2.21B |
— |
-35.67% |
— |
| PHVS |
Pharvaris N.V. |
$31.41 |
$2.19B |
— |
-61.24% |
— |
| VCEL |
Vericel Corporation |
$42.53 |
$2.18B |
83.65 |
6.91% |
— |
| ALMR |
Alamar Biosciences, Inc. |
$30.69 |
$2.13B |
— |
— |
— |
| IMNM |
Immunome, Inc. |
$17.99 |
$2.12B |
— |
-50.56% |
— |
| HRMY |
Harmony Biosciences Holdings, Inc. |
$36.13 |
$2.10B |
12.66 |
20.06% |
— |
| BHVN |
Biohaven Ltd. |
$13.88 |
$2.10B |
— |
— |
— |
| MRVI |
Maravai LifeSciences Holdings, Inc. |
$7.32 |
$2.08B |
— |
-35.42% |
— |
| ZYME |
Zymeworks Inc. |
$28.22 |
$2.02B |
— |
-72.07% |
— |
| VERA |
Vera Therapeutics, Inc. |
$27.99 |
$2.02B |
— |
-84.13% |
— |
| RXRX |
Recursion Pharmaceuticals, Inc. |
$3.70 |
$1.98B |
— |
-50.41% |
— |
| BCRX |
BioCryst Pharmaceuticals, Inc. |
$7.65 |
$1.95B |
— |
— |
— |
| SEPN |
Septerna, Inc. |
$40.41 |
$1.89B |
— |
-6.31% |
— |
| ADRX |
ADARx Pharmaceuticals, Inc. |
$17.63 |
$1.88B |
— |
— |
— |